RxDoctor Payments Data

Wael Hussein

Nephrology · Memphis, TNNPI 1104172378

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,750 of the $10,071 with a category attached, or 96.8%. GSK accounts for 97.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $9,829 and has fallen 98.6% since, to $142 in 2025.

$10,071in general payments, 2019–2025

Across 9 payments — averaging $1118.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$10K
  • Nxstage Medical, Inc.$100
  • Calliditas Therapeutics US Inc.$63
  • Bayer$56
  • Aurinia Pharma U.S., Inc.$23
$907,217in research payments, 2019–2025

Across 295 payments — averaging $3075.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Quanta Dialysis Technologies Inc$726K
  • CSL Behring$99K
  • Baxter Healthcare$82K

What the payments were for

  • Consulting fees$9,75097%
  • Travel & lodging$791%
  • Food & beverage$2412%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,071 in reported general payments places this provider in the 85th percentile of 229 nephrology providers in Tennessee.

See all nephrology providers in Tennessee →

Other nephrology in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →